Zynerba Pharmaceuticals, Inc.   Report issue

For profit Phase 3
Founded: Devon PA United States (2007)

Organization Overview

First Clinical Trial
2018
NCT03614663
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Zynerba Pharmaceuticals, Inc.